Peking University People's Hospital: Arthritis, Rheumatoid trials
The registry lists 12 Arthritis, Rheumatoid studies with Peking University People's Hospital as lead sponsor. 5 are open to participants now and 1 have results posted.
Phase 2 5No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid ArthritisRecruitingNCT07796516Phase 2
- A RWS of SC MTX in Chinese RA PatientsRecruitingNCT07463937
- Mass Spectrometry-based Immune Profiling in Autoimmune DiseasesEnrolling by invitationNCT07188285
- Fucoidan in the Treatment of Active Rheumatoid ArthritisRecruitingNCT07045896Not applicable
- Therapy of Niacin for Rheumatoid ArthritisNot yet recruitingNCT07004725Phase 2
- Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid ArthritisCompletedNCT02467504Phase 2Results posted
- Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.CompletedNCT07335952Phase 2
- Effect of Butyrate Supplement on Rheumatoid ArthritisCompletedNCT05576597Phase 2
- Tetrandrine in the Treatment of Rheumatoid ArthritisStatus unknownNCT05245448Not applicable
- Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid ArthritisStatus unknownNCT05240859
- The Treat-to-target Study of RA Based on Smart System of Disease Management(SSDM)Status unknownNCT03715595Not applicable
- Remission in Rheumatoid Arthritis in the Asian-Pacific RegionStatus unknownNCT03365856